CHONDROKIN (IGF1-C11)

CHONDROKIN (IGF1-C11)

Chondrokin is an antibody fusion protein, which delivers the anabolic factor IGF-1 to damaged cartilage, promoting  local repair and regeneration. 
 
The product is administered by intra-articular injection. In preclinical studies, Chondrokin demonstrated selective and persistent accumulation at the site of disease.  
Further proof-of-concept was obtained in a rat model of osteoarthritis, in which Chondrokin treatment resulted in significant cartilage protection.
 
The product is currently under pre-clinical investigation in a sheep model for the treatment of cartilage damage disorders, paving the way to future clinical applications for the treatment of cartilage defects and of osteoarthritis. 

This website or its third party tools use cookies, which are necessary to its functioning and required to achieve the purposes illustrated in the cookie policy. If you want to know more or withdraw your consent to all of the cookies, please refer to the cookie policy. By closing this banner, scrolling this page, clicking a link or continuing to browse otherwise, you agree to the use of cookies.

I Accept Cookie Policy
X